Where is the live CopyMark page for USPTO serial 78176056?

The live record is at https://getcopymark.com/trademark/78176056. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns THE PURPLE PILL?

According to the public USPTO record for serial number 78176056, the listed owner(s) include: AstraZeneca AB.

What is USPTO serial number 78176056?

Serial number 78176056 is the USPTO application identifier for the mark THE PURPLE PILL. It is used to track examination, publication, and registration of this trademark.

What is the current status of THE PURPLE PILL?

THE PURPLE PILL (78176056) currently shows USPTO status code 601 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover THE PURPLE PILL?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: THE PURPLE PILL Serial# 78176056 | status 601; last event EXPT | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THE PURPLE PILL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

AstraZeneca AB
Sodertalje, SE
Other trademarks owned by AstraZeneca AB

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark I. Peroff

MARK I PEROFF KIRKPATRICK & LOCKHART LLP599 LEXINGTON AVENEW YORK, NY 10022-6030UNITED STATES

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations for the treatment of gastrointestinal diseases.	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Oct 5, 2004	EXPT	EXPARTE APPEAL TERMINATED	—
Oct 5, 2004	MAB1	ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT	—
Oct 5, 2004	ABN1	ABANDONMENT - EXPRESS MAILED	—
Oct 5, 2004	EXAR	TEAS EXPRESS ABANDONMENT RECEIVED	—
Aug 16, 2004	MAIL	PAPER RECEIVED	—
Aug 5, 2004	MAIL	PAPER RECEIVED	—
Jun 18, 2004	MAIL	PAPER RECEIVED	—
Jun 18, 2004	EXPI	EX PARTE APPEAL-INSTITUTED	—
Jun 15, 2004	EXAF	EXPARTE APPEAL RECEIVED AT TTAB	—
Jun 7, 2004	MAIL	PAPER RECEIVED	—
Mar 26, 2004	TCCA	TEAS CHANGE OF CORRESPONDENCE RECEIVED	—
Dec 5, 2003	GNFR	FINAL REFUSAL E-MAILED	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 2, 2003	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Oct 2, 2003	MAIL	PAPER RECEIVED	—
Mar 31, 2003	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2003	DOCK	ASSIGNED TO EXAMINER	—

THE PURPLE PILL